Masavibart
Masavibart (ZRC3308-A7) is an anti-SARS-CoV-2 monoclonal antibody (IgG1 type). Masavibart shows good binding affinity to a non-competing epitope on the RBD of the SARS-CoV-2 spike protein. Masavibart can be used in combination with ZRC3308-B10 at a ratio of 1:1, which is effective for the prevention of COVID-19 and the early stage of COVID-19 before the development of severe disease[1].
Product Specifications
CAS Number
2640223-84-1
Product Name Alternative
ZRC3308-A7
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/masavibart.html
Solubility
10 mM in DMSO
Smiles
[Masavibart]
References & Citations
[1]Yadav PD, et al. ZRC3308 Monoclonal Antibody Cocktail Shows Protective Efficacy in Syrian Hamsters against SARS-CoV-2 Infection. Viruses. 2021 Dec 3;13 (12) :2424.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15103335 1 Vial
Lentiviral human OTUD4 shRNA (UAS) - Lentiviral human OTUD4 shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
RC230582L4V 200 µL
BCAR1 (NM_001170714) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details